Registry studies of long-term multiple sclerosis outcomes
Description of key registries
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background: Multiple sclerosis (MS) registries can provide valuable insights into the natural history of MS. Key observational findings of the registries include MS patient disability progression rate, predictors of increased disability, and changes in lifespan. MS registries have been established in Canada, the United States, and Europe, some of which have existed for decades. Recommendations for registry use and improvement based on a review of a selection of MS registries from these countries are presented.
Methods: A panel of experts analyzed the current status of a number of the established MS registries and made recommendations on their usefulness and on improvements for the creation of future MS registries.
Results: Improved inter-registry consistency in order to better compare and contrast the results of different registries was advocated. To follow the course of MS, the initiation of a prospective, complete, verifiable database of patients with clinically isolated syndrome was also recommended. Time to Expanded Disability Status Scale 6 was supported over mortality as the central endpoint of a registry study, because it can be detected earlier in the course of the disease than mortality.
Conclusions: The data collected from registries are considered valuable in understanding MS, despite difficulties with registries such as a lack of consistency between their databases.
Footnotes
-
- BCMS
- British Columbia Multiple Sclerosis
- COSTAR
- Computer Stored Ambulatory Record
- DMT
- disease-modifying therapy
- EDMUS
- European Database for Multiple Sclerosis
- EDSS
- Expanded Disability Status Scale
- ICD-9-CM
- International Classification of Diseases, Ninth Revision, Clinical Modification
- MS
- multiple sclerosis
- NARCOMS
- North American Research Committee on Multiple Sclerosis
- NYSMSC
- New York State Multiple Sclerosis Consortium
- VHA
- Veterans Health Administration.
-
This Neurology® supplement is not peer-reviewed. Information contained in this Neurology® supplement represents the opinions of the authors. These opinions are not endorsed by nor do they reflect the views of the American Academy of Neurology, Editor-in-Chief, or Associate Editors of Neurology®.
- Copyright © 2010 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Analysis of current multiple sclerosis registriesBarrie J. Hurwitz et al.Neurology, December 27, 2010 -
Article
Disability in multiple sclerosisA reference for patients and cliniciansIlya Kister, Eric Chamot, Amber R. Salter et al.Neurology, February 20, 2013 -
Articles
Disparities in the management of multiple sclerosis–related bladder symptomsR. A. Marrie, G. Cutter, T. Tyry et al.Neurology, June 04, 2007 -
Articles
Comorbidity delays diagnosis and increases disability at diagnosis in MSR. A. Marrie, R. Horwitz, G. Cutter et al.Neurology, October 29, 2008